The IMA Group Acquires Amici Clinical Research
March 2, 2022
The IMA Group's Clinical Research division acquired Amici Clinical Research, adding two New Jersey clinical trial sites (Raritan and Hoboken) to IMA's network. The acquisition expands IMA's Northeast footprint and therapeutic capabilities across areas including fatty liver, cardiovascular, pulmonary and neurologic diseases, and supports site-based, hybrid and decentralized trials.
- Buyers
- The IMA Group (IMA Clinical Research)
- Targets
- Amici Clinical Research
- Platforms
- IMA Clinical Research
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.